Menu

Experience

Mark Weeks

    • Unchained Labs Agrees to Sell to The Carlyle Group 


    • Cardiva Medical agrees to sell to Haemonetics for $475 million 


    • Pulmonx – $218.5 Million IPO 


    • Cardiva Medical Closes $45 Million Financing 


    • Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy 


    • Establishment Labs – $76 Million IPO 


    • Progyny – $150 Million IPO 


    • Auxogyn and Fertility Authority Announce Merger 


    • Guardant Health Series D Financing 


    • Iconic Therapeutics Series C Financing 


    • Nexvet Biopharma Closes Initial Public Offering 


    • CardioKinetix Completes $50 Million Financing 


    • ProteinSimple $300 Million Sale to Techne Corporation 


    • Revance $110 Million Initial Public Offering 


    • Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • AcelRx Pharmaceuticals in Public Offering 


    • IDEV Technologies $310 Million Acquisition by Abbott Labs 


    • Lucira Health – $175.95 Million IPO